ロード中...
Chemo-immune synergetic therapy of esophageal carcinoma: trastuzumab modified, cisplatin and fluorouracil co-delivered lipid–polymer hybrid nanoparticles
Esophageal cancer is the sixth most common cause of cancer-related death worldwide. Peptide modified nanoparticles have been engineered as novel strategies to improve esophageal adenocarcinoma (EAC) therapy. This study aimed to develop a trastuzumab (TAB) modified system for the delivery of cisplati...
保存先:
| 出版年: | Drug Deliv |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7598994/ https://ncbi.nlm.nih.gov/pubmed/33118428 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2020.1837294 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|